Richard Paul Russo Jr - 06 Oct 2022 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
CEO and President
Signature
/s/ Rich Russo
Issuer symbol
BNKL
Transactions as of
06 Oct 2022
Net transactions value
$0
Form type
4
Filing time
13 Oct 2022, 13:17:20 UTC
Previous filing
15 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNKL Employee Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 06 Oct 2022 Common Stock, par value $0.001 60,000 $0.3020 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 1/3 on each of the first three anniversaries of the grant date.